Generic Ozempic Approved in Canada

0:00Health Canada just greenlit the first generic version of ozempic, that semi-glutide injection from Novo Nordisk. It's made by India's Dr. Reddy's laboratories, and Canada beats every other group of seven country to the punch on this approval. The drug treats type two diabetes and adults with a once a week shot. They submitted it early this year, and it's already sold as albeda back in India. Health Canada has eight more generic versions in the pipeline for review, so more options could drop soon. Experts like doctors from McMaster and McGill say these generics are chemically almost identical to the brand name stuff. Thanks to the strict, approval process, no big differences in how they work. The real game changer is the price brand ozempic runs 200 to 450 dollars a month, but generics could slash that to 40 or 80 bucks. That's 45 to 90 percent cheaper, easing the hit on wallets and even boosting research. Provinces decide if it'll hit public drug plans, so coverage varies.

1:02Long term, it could cut obesity and heart disease costs for the health system, but docs warn it's a lifelong commitment, stop the shots, and the benefits fade fast. Keep an eye on this shift. Local news, powered by AI, this is Canada News Today.